BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33015626)

  • 1. Characteristics of mutational signatures of unknown etiology.
    Hu X; Xu Z; De S
    NAR Cancer; 2020 Sep; 2(3):zcaa026. PubMed ID: 33015626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of mutational and copy number signatures in human cancer.
    Steele CD; Pillay N; Alexandrov LB
    J Pathol; 2022 Jul; 257(4):454-465. PubMed ID: 35420163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Mutational Processes Vary in Their Association with Replication Timing and Chromatin Accessibility.
    Yaacov A; Vardi O; Blumenfeld B; Greenberg A; Massey DJ; Koren A; Adar S; Simon I; Rosenberg S
    Cancer Res; 2021 Dec; 81(24):6106-6116. PubMed ID: 34702725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures.
    Lee J; Lee AJ; Lee JK; Park J; Kwon Y; Park S; Chun H; Ju YS; Hong D
    Nucleic Acids Res; 2018 Jul; 46(W1):W102-W108. PubMed ID: 29790943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MutationalPatterns: comprehensive genome-wide analysis of mutational processes.
    Blokzijl F; Janssen R; van Boxtel R; Cuppen E
    Genome Med; 2018 Apr; 10(1):33. PubMed ID: 29695279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns.
    Sørensen SG; Shrikhande A; Poulsgaard GA; Christensen MH; Bertl J; Laursen BE; Hoffmann ER; Pedersen JS
    Elife; 2023 Mar; 12():. PubMed ID: 36883553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Mutational Signatures Using the mutSignatures R Library.
    Fantini D; Meeks JJ
    Methods Mol Biol; 2023; 2684():45-57. PubMed ID: 37410227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoding whole-genome mutational signatures in 37 human pan-cancers by denoising sparse autoencoder neural network.
    Pei G; Hu R; Dai Y; Zhao Z; Jia P
    Oncogene; 2020 Jul; 39(27):5031-5041. PubMed ID: 32528130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear topology modulates the mutational landscapes of cancer genomes.
    Smith KS; Liu LL; Ganesan S; Michor F; De S
    Nat Struct Mol Biol; 2017 Nov; 24(11):1000-1006. PubMed ID: 28967881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events.
    Bergstrom EN; Huang MN; Mahto U; Barnes M; Stratton MR; Rozen SG; Alexandrov LB
    BMC Genomics; 2019 Aug; 20(1):685. PubMed ID: 31470794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational processes molding the genomes of 21 breast cancers.
    Nik-Zainal S; Alexandrov LB; Wedge DC; Van Loo P; Greenman CD; Raine K; Jones D; Hinton J; Marshall J; Stebbings LA; Menzies A; Martin S; Leung K; Chen L; Leroy C; Ramakrishna M; Rance R; Lau KW; Mudie LJ; Varela I; McBride DJ; Bignell GR; Cooke SL; Shlien A; Gamble J; Whitmore I; Maddison M; Tarpey PS; Davies HR; Papaemmanuil E; Stephens PJ; McLaren S; Butler AP; Teague JW; Jönsson G; Garber JE; Silver D; Miron P; Fatima A; Boyault S; Langerød A; Tutt A; Martens JW; Aparicio SA; Borg Å; Salomon AV; Thomas G; Børresen-Dale AL; Richardson AL; Neuberger MS; Futreal PA; Campbell PJ; Stratton MR;
    Cell; 2012 May; 149(5):979-93. PubMed ID: 22608084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence dependencies and mutation rates of localized mutational processes in cancer.
    Poulsgaard GA; Sørensen SG; Juul RI; Nielsen MM; Pedersen JS
    Genome Med; 2023 Aug; 15(1):63. PubMed ID: 37592287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence network model uncovers relations between biological processes and mutational signatures.
    Amgalan B; Wojtowicz D; Kim YA; Przytycka TM
    Genome Med; 2023 Mar; 15(1):15. PubMed ID: 36879282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational signatures and mutable motifs in cancer genomes.
    Rogozin IB; Pavlov YI; Goncearenco A; De S; Lada AG; Poliakov E; Panchenko AR; Cooper DN
    Brief Bioinform; 2018 Nov; 19(6):1085-1101. PubMed ID: 28498882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
    Meier B; Volkova NV; Gerstung M; Gartner A
    DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topography of mutational signatures in human cancer.
    Otlu B; Díaz-Gay M; Vermes I; Bergstrom EN; Zhivagui M; Barnes M; Alexandrov LB
    Cell Rep; 2023 Aug; 42(8):112930. PubMed ID: 37540596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the genomic landscape of colorectal cancer through mutational signatures.
    Díaz-Gay M; Alexandrov LB
    Adv Cancer Res; 2021; 151():385-424. PubMed ID: 34148618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational signature distribution varies with DNA replication timing and strand asymmetry.
    Tomkova M; Tomek J; Kriaucionis S; Schuster-Böckler B
    Genome Biol; 2018 Sep; 19(1):129. PubMed ID: 30201020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers.
    Farmanbar A; Firouzi S; Kneller R; Khiabanian H
    J Transl Med; 2022 Feb; 20(1):65. PubMed ID: 35109853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational signature SBS8 predominantly arises due to late replication errors in cancer.
    Singh VK; Rastogi A; Hu X; Wang Y; De S
    Commun Biol; 2020 Aug; 3(1):421. PubMed ID: 32747711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.